Private Health Investments Under Competing Risks: Evidence from Malaria Control in Senegal

53 Pages Posted: 8 May 2020

See all articles by Pauline Rossi

Pauline Rossi

University of Amsterdam

Paola Villar

Paris School of Economics (PSE)

Multiple version iconThere are 2 versions of this paper

Date Written: May 2020

Abstract

This study exploits the introduction of high subsidies for anti-malaria products in Senegal in 2009 to investigate whether malaria prevents parents from investing in child health. A simple model of health investments under competing mortality risks predicts that private expenses to fight malaria and other diseases should increase in response to anti-malaria public interventions. We test and validate this prediction using original panel data from a household expenditure survey combined with geographical information on malaria prevalence. We find that health expenditures in malarious regions catch up with non-malarious regions. The same result holds for parental health-seeking behavior against other diseases like diarrhea. These patterns cannot be explained by differential trends between regions. Our results suggest that behavioral responses to anti-malaria campaigns magnify their impact on all-cause mortality for children.

Keywords: Africa, Competing Risks, Health expenses, Human Capital, Malaria

JEL Classification: D1, H51, I1, J13, O15

Suggested Citation

Rossi, Pauline and Villar, Paola, Private Health Investments Under Competing Risks: Evidence from Malaria Control in Senegal (May 2020). CEPR Discussion Paper No. DP14705, Available at SSRN: https://ssrn.com/abstract=3594340

Pauline Rossi (Contact Author)

University of Amsterdam ( email )

Spui 21
Amsterdam, 1018 WB
Netherlands

Paola Villar

Paris School of Economics (PSE) ( email )

48 Boulevard Jourdan
Paris, 75014 75014
France

Here is the Coronavirus
related research on SSRN

Paper statistics

Downloads
0
Abstract Views
25
PlumX Metrics